HTG Releases Second Whitepaper for its Transcriptome-Informed Approach to Drug Discovery
Summary by Ground News
HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, has released a second white paper. The White Paper describes the use of HTG’s Transcriptome Panel (HTP) in early-stage design, selection and characterization of small-molecule candidates.1 month ago·Tucson, United States
News Articles
More Filters
All
Left
Center
Right
Time & Location
Sources are mostly out of (0)
Bias Distribution
No sources with tracked biases.
See less detail
